Yinggang Zhang
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.
Journal: Free radical biology & medicine
Published: July 24, 2025
Pharmacological Targeting of NRF2 Represents a Promising Therapeutic Approach for Pyroptosis-Related Non-Alcoholic Fatty Liver Disease.
Journal: Current medicinal chemistry
Published: June 04, 2025
Reactive Oxygen Species-Mediated TRPM2 Activation Facilitates Phagocytosis of Macrophages to Reverse Profibrotic Phenotype.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 21, 2024
Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 11, 2024
Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy.
Journal: Metabolites
Published: August 31, 2024
Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway.
Journal: Free radical biology & medicine
Published: July 13, 2024
Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.
Journal: Cell biology and toxicology
Published: June 26, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026